Skip to main content
. 2021 Sep 1;4(4):434–438. doi: 10.31662/jmaj.2021-0027

Table 2.

Review of the Published Literatures on Renal Artery Aneurysms in Patients with Granulomatosis with Polyangiitis.

Author, Year No. of patients Age Sex Diagnostic tool for GPA Aneurysmal symptoms Hemodynamics Diagnostic tool for aneurysms Duration between aneurysm and GPA diagnosis Involved artery Rupture artery aneurysm Treatment Outcome
Baker, 1978 (2) 1 24 male Biopsy Rt. flank pain, shock Unstable Angiography 2 days Renal Yes (renal) AE (gelfoam) Recovery
Moutsopoulos, 1983 (3) 2 30 male Biopsy NA Stable Angiography 4 months Renal No Immunosupression NA
53 female Clinical featues NA Stable Angiography 1 month Renal No Immunosupression NA
Senf, 2003 (4) 1 35 male Biopsy, PR3-ANCA Lt. flank pain, shock Unstable CT 24 days Hepatic, renal, splanchnic Yes (hepatic) Immunosupression Recovery
Arlet, 2007 (5) 1 29 male Biopsy, PR3-ANCA Abdominal pain, vomitting Stable CT 5 years PD, Hepatic, renal No AE (coil, for hepatic artery) Recovery
Carron, 2011 (6) 1 79 male Clinical features, PR3-ANCA Shock due to colon hematoma Unstable Angiography 4 weeks Renal No Immunosupression Recovery
Boersma, 2013 (7) 1 51 female PR3-ANCA Lower abdominal and flank pain Unstable Angiography 15 years Renal Yes (renal) AE Recovery
Kim, 2017 (8) 1 71 male Biopsy, PR3-ANCA none Stable CT concomitant Renal No Immunosupression Recovery
Mahmudpour, 2018 (9) 1 60 male PR3-ANCA Rt. flank pain, shock Unstable CT NA Renal Yes (renal) Nephrectomy Died due to renal failure
Skonieczny, 2019 (10) 1 50 male Clinical features, PR3-ANCA Rt. flank pain, shock Unstable CT 15 days Renal Yes (renal) AE (coil), immunosupression Died due to infection
Present case 1 75 female Clinical features, PR3-ANCA Abdominal pain, shock Unstable CT 20 days Renal Yes (renal) AE (coil), immunosupression Recovery

AE, arterial embolization; CT, computed tomography; GPA, gramulomatosis with polyangitis; Lt, left; NA, no available; PD, pancreatic-duodena; PR3-ANCA, proteinase3-anti-neutrophil cytoplasmic antibodies; and Rt, right